Adicet Bio, Inc. Variable Lease, Cost
Adicet Bio, Inc. (ACET) reported Variable Lease, Cost of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2022-11-08
- Adicet Bio, Inc. variable lease, cost for the quarter ending 2022-09-30 was $0.00.
- Adicet Bio, Inc. variable lease, cost for the quarter ending 2022-06-30 was $0.00.
- Adicet Bio, Inc. variable lease, cost for the quarter ending 2022-03-31 was $0.00.
- Adicet Bio, Inc. variable lease, cost for fiscal 2021 was $0.00.
- Adicet Bio, Inc. variable lease, cost for fiscal 2020 was $0.00.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |